18 completed, 10 recruiting, 5 unknown, 3 active not recruiting. 12 Phase 2, 8 Phase 1, 3 Not applicable, 2 Phase 4, 1 Early Phase 1.
Follow Bunyaviridae Infections: new trials by email Literature Review of Bunyaviridae Infections trials Research Report on Bunyaviridae Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF Favipiravir, Ribavin, Optimised Standard of Care - Crimean-Congo Hemorrhagic Fever | Phase 2 | Recruiting | Liverpool School of Tropical Medicine | 378 | 2026-06-04 | 2026-08-07 |
| Natural History of Andes Virus Infection Andes Hantavirus | Active not recruiting | Assistance Publique - Hôpitaux de Paris | 15 | 2026-05-19 | 2026-07-14 | |
| Biomedical Signal Extraction From Symptom Descriptions: An Observational Registry Using the OpenGenome Platform OpenGenome AI Platform - Signs and Symptoms, Fever | Recruiting | OpenGenome | 1000 | 2026-05-05 | 2026-05-19 | |
| Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care Rapid Diagnostic Test - Crimean-Congo Haemorrhagic Fever | Not applicable | Recruiting | Liverpool School of Tropical Medicine | 492 | 2026-05-04 | 2026-06-09 |
| Characterising the Loss of Haemostasis in Haemorrhagic Fever With Renal Syndrome Blood draw for thromboelastography - admission, Blood draw for thromboelastography - follow-up, Blood draw for transcriptomic analysis - Haemorrhagic Fever With Renal Syndrome | Not yet recruiting | Liverpool School of Tropical Medicine | 62 | 2026-05-01 | 2025-11-19 | |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever 10 ug HDT 321, 25ug HDT-321, 50ug HDT-321 - Vaccine, Crimean-Congo Hemorrhagic Fever | Phase 1 | Recruiting | HDT Bio | 48 | 2025-07-10 | 2025-07-28 |
| Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003) ChAdOx1 RVF, Rabies Vaccine - Rift Valley Fever | Phase 2 | Active not recruiting | University of Oxford | 240 | 2025-07-08 | 2025-11-17 |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011 IDB-011 dose level 1, IDB-011 dose level 2, IDB-011 dose level 3 - Rift Valley Fever | Phase 1 | Active not recruiting | IDBiologics, Inc. | 40 | 2025-04-02 | 2026-03-25 |
| Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases Peripheral venous blood sample - Leishmaniasis, Leptospirosis | Not applicable | Not yet recruiting | University Hospital, Montpellier | 183 | 2025-03-03 | 2025-03-05 |
| RVF and Other Emerging Infectious Diseases in East and Central Africa Evidence of past or recent RVF exposure - Rift Valley Fever, Hemorrhagic Fevers, Viral | Recruiting | Washington State University | 5000 | 2025-02-01 | 2026-10-05 | |
| OBSERVATIONAL STUDY ON VIRAL SHEDDING AND IMMUNOLOGICAL RESPONSE OF OROPOUCHE VIRUS Oropouche Infection | Recruiting | IRCCS Sacro Cuore Don Calabria di Negrar | 30 | 2024-12-19 | 2025-05-18 | |
| Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever N-pVAX1 - Crimean Congo Hemorrhagic Fever | Phase 1 | Completed | Karolinska Institutet | 15 | 2024-11-12 | 2026-03-23 |
| Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS) Methylprednisolone, intravenous immunoglobulin, Tocilizumab - Severe Fever With Thrombocytopenia Syndrome | Phase 4 | Unknown | Qin Ning | 350 | 2022-08-19 | 2023-07-21 |
| Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study IVIG 20g/d, IVIG 10g/d - HFRS (Hemorrhagic Fever With Renal Syndrome) | Phase 4 | Unknown | Tongji Hospital | 100 | 2022-07-01 | 2023-08-24 |
| A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults ChAdOx1 RVF, Saline - RVF, Rift Valley Fever | Phase 1 | Completed | University of Oxford | 30 | 2022-05-31 | 2023-02-06 |
| Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools HANTA-NE - Hantavirus Nephropathy, Hantavirus Infection | Completed | Central Hospital, Nancy, France | 101 | 2022-05-20 | 2025-02-24 | |
| A Retrospective Cohort Study of HFRS HFRS | Unknown | Tongji Hospital | 500 | 2022-05-05 | 2023-08-31 | |
| A 6-month Follow-up Study of Patients With Severe Fever With Thrombocytopenia Syndrome Severe Fever With Thrombocytopenia Syndrome | Unknown | Tongji Hospital | 1500 | 2021-10-25 | 2023-08-25 | |
| Safety/Immunogenicity Hantaan Virus DNA Vaccine and Puumala Virus DNA Vaccine, For Prevention of HFRS Hantaan DNA Vaccine/Puumala DNA Vaccine - Hantaan Virus Nephropathy, Puumala Virus Nephropathy | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 132 | 2021-08-23 | 2026-05-19 |
Showing 20 of 42. Sign in to see all of them.
Hemorrhagic Fever with Renal Syndrome (14) · Rift Valley Fever (11) · Hantavirus Infections (6) · Hemorrhagic Fever, Crimean (6) · Hantavirus Pulmonary Syndrome (5) · Hemorrhagic Fevers, Viral (4) · Brucellosis (3) · Severe Fever with Thrombocytopenia Syndrome (3) · Arbovirus Infections (2) · Chikungunya Fever (2) · Encephalitis, Tick-Borne (2) · Hepatitis E (2) · Leishmaniasis (2) · Leptospirosis (2)
Infections (42) · RNA Virus Infections (42) · Virus Diseases (40) · Hemorrhagic Fevers, Viral (27) · Vector Borne Diseases (20) · Hantavirus Infections (17) · Arbovirus Infections (16) · Animal Diseases (12) · Digestive System Diseases (12) · Hepatitis (12) · Liver Diseases (12) · Mosquito-Borne Diseases (12) · Hepatitis, Animal (11) · Hepatitis, Viral, Animal (11)
Ribavirin (4) · Immunoglobulins, Intravenous (2) · Methylprednisolone (2) · Anti-Bacterial Agents (1) · Blood Specimen Collection (1) · Desiccation (1) · Heparin, Low-Molecular-Weight (1) · Immunoglobulin M (1) · Injections (1) · Rabies Vaccines (1) · Rapid Diagnostic Tests (1) · Sodium Chloride (1) · Vaccines (1) · favipiravir (1) · tocilizumab (1)
U.S. Army Medical Research and Development Command (11) · Liverpool School of Tropical Medicine (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Tongji Hospital (3) · University of Oxford (3) · University of New Mexico (2) · Assistance Publique - Hôpitaux de Paris (1) · Central Hospital, Nancy, France (1) · Centre Hospitalier de Charleville-Mézières (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · HDT Bio (1) · Huashan Hospital (1) · IDBiologics, Inc. (1) · IRCCS Sacro Cuore Don Calabria di Negrar (1) · Institut Pasteur du Cambodge (1)
United States (12) · China (6) · France (4) · Germany (4) · Kenya (3) · Chile (2) · Turkey (Türkiye) (2) · Uganda (2) · Cambodia (1) · Canada (1) · Democratic Republic of the Congo (1) · Italy (1) · South Korea (1) · Sweden (1) · Tanzania (1)
Qin Ning, Professor (2) · Adrian VS Hill, Prof (1) · Claude Flamand, Ph.D. (1) · Elizabeth Rini (1) · Elizabeth Rini, MD (1) · Gregory Mertz, MD (1) · James E Moon, MD (1) · Janice Rusnak, MD (1) · Jean Marc Galempoix, MD (1) · Kirsten E Lyke, MD (1) · Kristopher Paolino, MD (1) · Laura M Cashin, DO (1)
PMID 23784924, PMID 37060917, PMID 37380156, PMID 37486218, PMID 38608217, PMID 41237791, PMID 41652539
U01AI151799 (1)